SIRUM

SIRUM, short for Supporting Initiatives to Redistribute Unused Medicine, is a United States nonprofit social enterprise focused on reducing pharmaceutical waste and improving access to prescription drugs. Its model addresses two connected problems: healthcare organizations dispose of substantial quantities of unopened, unexpired medicine, while many uninsured and underinsured patients struggle to obtain the medicines they need. Rather than treating surplus medicine as waste, SIRUM coordinates its transfer from organizations that no longer need it to qualified community-based providers that can distribute it to patients. The organization was started by three Stanford University students and began its work in California. Its first redistribution activity connected a nursing home serving as a donor with a recipient facility in Santa Clara County. SIRUM subsequently expanded beyond California, beginning multistate growth in 2014. The organization’s work operates within the legal and regulatory framework created by state drug-repository and Good Samaritan laws. According to the referenced material, such protections and guidelines exist in 44 states, although the precise requirements governing eligible donors, medicines, recipients, documentation, and dispensing vary by jurisdiction. SIRUM’s operating model combines logistics, compliance support, and software. Donors—including long-term-care facilities and licensed pharmacies—place qualifying unopened and unexpired medications into SIRUM’s recycling boxes. The medicines are packaged and shipped to community partners such as safety-net providers, nonprofit pharmacies, and drug-repository programs. Those partners’ pharmacists or other authorized healthcare professionals then dispense the medicines to patients. SIRUM’s online platform supports matching, record-keeping, shipping, and related administrative processes, making donation more practical than destroying usable inventory. The organization frames medicine redistribution as both an access intervention and an environmental strategy. Reusing medicine can reduce the need for duplicate purchasing and manufacturing, while diverting usable products from destruction may lessen associated waste and pollution. Its case for redistribution is particularly strong for institutional surplus, where medicines remain under professional control and their condition can be monitored throughout the product life cycle. SIRUM has combined direct operations with public advocacy and sector recognition. It participated in Y Combinator in 2015 and received coverage in The New York Times. In 2019, it was recognized by the U.S. Agency for International Development and the U.S. Environmental Protection Agency as an innovator in waste reduction. In 2020, the organization appeared on the TED Conference mainstage and became a grantee of the Audacious Project. The latter initiative set an ambition to redistribute $772 million in prescription medicine and reach one million patients. As of December 2024, SIRUM reported that it had facilitated redistribution of $280 million worth of medicine, processed more than 40,000 donations through its platform, and helped over 300,000 uninsured and underinsured patients access life-saving medicines. These figures are organization-reported impact measures rather than conventional commercial sales figures. SIRUM’s identity is therefore best understood as a mission-driven healthcare-access and medication-reuse platform rather than as a pharmaceutical manufacturer, pharmacy chain, or conventional consumer brand.

SIRUM was created by three Stanford University students who sought to address the simultaneous waste of usable medicine and difficulty many Americans face in affording prescription treatment. The organization’s name derives from Supporting Initiatives to Redistribute Unused Medicine. Its founding concept was that surplus drugs held by healthcare institutions could be safely redirected to patients through qualified community providers rather than destroyed. SIRUM began in California. Its initial operation connected a nursing home donating unused medicine with a recipient facility in Santa Clara County. This early model established the basic structure that remains central to the organization: an institutional donor, a community healthcare recipient, and a controlled transfer of unopened and unexpired medicine for dispensing to eligible patients. SIRUM later began expanding into other states in 2014. The organization developed a technology and logistics layer around medicine donation. It supplies recycling boxes to donors such as long-term-care facilities and licensed pharmacies, helps coordinate packaging and shipping, and provides an online system for documentation and record-keeping. Community partners—including safety-net providers, nonprofit pharmacies, and drug-repository programs—receive the medicines and rely on authorized healthcare professionals to distribute them. This approach is intended to reduce the administrative burden and uncertainty that can otherwise make organizations more likely to destroy surplus inventory. SIRUM’s work is conducted within state-specific legal frameworks for drug donation and redistribution. Good Samaritan protections and drug-repository laws provide legal safeguards and operating guidance in many states; the referenced material states that such laws have passed in 44 states. Because these programs are regulated locally, eligibility, documentation, packaging, storage, and dispensing conditions can differ by jurisdiction. In 2015, SIRUM participated in Y Combinator and was featured in The New York Times. These developments helped present medication redistribution as a scalable social-enterprise and technology problem rather than only as a local charity activity. In 2019, SIRUM received recognition from USAID and the EPA for innovation in waste reduction. In 2020, it appeared on the TED Conference mainstage and was selected as an Audacious Project grantee. The Audacious Project initiative proposed redistributing $772 million in prescription medication and reaching one million patients. SIRUM’s mission has two principal dimensions. The first is healthcare access: medicines that would otherwise be discarded can help uninsured and underinsured people obtain treatment through safety-net channels. The second is resource conservation: reuse can reduce pharmaceutical destruction and potentially reduce duplicative manufacturing and purchasing. The organization’s rationale is especially focused on institutional surplus, where trained healthcare personnel can help preserve medicine integrity. By December 2024, SIRUM reported that its platform had supported more than 40,000 medicine donations, facilitated redistribution valued at $280 million, and helped more than 300,000 uninsured and underinsured patients access life-saving medications. These are reported program outcomes, not revenue or sales figures. SIRUM remains an active nonprofit-oriented organization whose principal role is to connect surplus medicine with community healthcare capacity in the United States.

• 2024

  Reported cumulative impact reaches $280 million in redistributed medicine

  [3]Reported cumulative impact reaches $280 million in redistributed medicinesirum.org

  By December 2024, SIRUM reports more than 40,000 donations, $280 million worth of redistributed medicine, and more than 300,000 patients reached.

• 2020

  TED appearance and Audacious Project grant

  [1]SIRUM (organization)en.wikipedia.org

  SIRUM appears on the TED Conference mainstage and is selected as an Audacious Project grantee.

• 2019

  Recognition for waste-reduction innovation

  [1]SIRUM (organization)en.wikipedia.org

  USAID and the EPA recognize SIRUM as an innovator in global waste reduction.

• 2015

  Y Combinator participation and national media attention

  [1]SIRUM (organization)en.wikipedia.org

  SIRUM participates in Y Combinator and is featured in The New York Times.

• 2014

  Expansion to additional states

  [1]SIRUM (organization)en.wikipedia.org

  SIRUM begins expanding its medicine-redistribution work beyond California.

• SIRUM is founded by Stanford students

  [1]SIRUM (organization)en.wikipedia.org

  Three Stanford University students establish SIRUM to reduce pharmaceutical waste and redirect usable medicine to people served by safety-net organizations.

• First California redistribution operation

  [1]SIRUM (organization)en.wikipedia.org

  SIRUM begins by connecting a nursing-home donor with a recipient facility in Santa Clara County.

A technology-enabled nonprofit infrastructure provider for safe medicine reuse, positioned at the intersection of pharmaceutical-waste reduction, healthcare access, and community health.

• Healthcare logistics and technology

  SIRUM redistribution platform

  SIRUM’s online platform connects organizations with surplus, unopened, unexpired medicine to community partners that can dispense it to patients. It supports donor and recipient matching, documentation, record-keeping, shipping coordination, and other administrative tasks involved in compliant medicine redistribution.

• Donation logistics

  Medicine recycling boxes

  SIRUM provides recycling boxes for institutional donors such as long-term-care facilities and licensed pharmacies. Donors use the boxes to collect and package qualifying unused medicines for shipment to approved community healthcare partners instead of sending the products for destruction.

• Healthcare access service

  Medication redistribution service

  The core service manages transfers of surplus prescription medicine from healthcare organizations to safety-net providers, nonprofit pharmacies, and drug-repository programs. Recipient organizations’ pharmacists or healthcare providers then distribute the medicine to eligible patients under applicable state rules.

• 2020Audacious Project medicine redistribution initiative

  United States

  SIRUM’s Audacious Project initiative sought to scale its model so that $772 million worth of prescription medicine could be redistributed to one million patients.

  Outcome. The initiative brought large-scale philanthropic and public attention to SIRUM’s medicine-reuse model. The supplied material does not establish whether the stated target was fully achieved.

  Source

• 2020

  Pursue national-scale medication redistributionStrategy

  Background

  SIRUM used the Audacious Project to articulate a large-scale ambition for reducing medicine waste and expanding patient access.

  Action taken

  The organization proposed redistributing $772 million worth of prescription medicine to one million patients.

  Aftermath

  The proposal increased the visibility of SIRUM’s model and framed medicine reuse as a scalable national intervention. The supplied sources do not confirm full target attainment.

  Target value of prescription medicine to redistribute. $772 million target (2020 initiative)

  Source

• 2014

  Expand medicine redistribution beyond CaliforniaStrategy

  Background

  After beginning with a California nursing-home and recipient-facility connection, SIRUM sought to extend its model to additional states.

  Action taken

  SIRUM began multistate expansion, working within state drug-repository and Good Samaritan frameworks.

  Aftermath

  The expansion established the basis for a broader U.S. redistribution network. The supplied material does not provide a state-by-state rollout or financial results.

  Source

1. 1SIRUM (organization)en.wikipedia.org
2. 2SIRUM official websitesirum.org
3. 3Reported cumulative impact reaches $280 million in redistributed medicinesirum.org